Chronic pain in childhood is underrecognized, and clinicians are unfamiliar with treatment options and symptom management in children with chronic medical conditions.
PAIN HISTORY
A patient's pain history is often obtained as part of the routine history during medical encounters. Pain is usually easy to assess in an adult, but how does one assess pain in a pediatric patient from infancy to adolescence? Pain management continues to be an area of uncertainty for clinicians. Common concerns include, "If I treat the pain with an opioid, I might make the patient a drug addict." or "If I undertreat the pain, it might result in my patient missing school, having behavioral issues, or being depressed." Multiple modalities, including nonpharmacologic interventions, are available to help control a patients' pain.
As with most diagnoses in medicine, the answer to treating a patient's pain lies in the details of the history. It is essential to obtain a thorough pain history from the patient, if possible, and collaborate with the caregivers. Of note, it is the patient's history that matters. Even patients as young as 2 years can answer very basic questions related to their pain. Research has demonstrated that parents may underestimate their child's postoperative pain, but they can reliably offer observations and judgments about a young child's pain behaviors, responses, and factors that may exacerbate or ameliorate pain when presented in a structured format (Table 1) . (1) The details of a thorough pain history include asking questions related to when the pain first started, what makes it worse, and what makes it better. The quality of the pain should be defined: sharp, dull, feels like pressure or pulling, cramping, stabbing, needlelike, or burning. Does the pain radiate and if so, to where? Is the pain constant or intermittent; does it come on suddenly or start slowly; and does it interrupt particular daily functions, activities, or sleep? What does the patient do to make the pain go away? What interventions, including medications, physical therapy, or other modalities, have been tried and what was the response? The history and answers to these questions can guide the differential diagnosis of the type of pain: somatic, visceral or neuropathic (Table 2) . Treatment options differ for each type of pain.
PAIN SCALES
Validated pain scores or rating scales should be used to measure and assess the severity of pain consistently. The effectiveness of the treatment plan can be evaluated using the same rating scale. Pain rating scales are available for infants, nonverbal patients, and patients who are able to verbalize a response. The scales are multimodal and incorporate behavioral and physiologic components, including facial expression (grimace), extremity position and movement (flexion), body habitus (stillness or inability to get comfortable), heart rate, blood pressure, and oxygen saturation. Examples include:
• Neonatal Infant Pain Scale (NIPS) (2), a behavioral assessment tool for preterm and term neonates up to 6 weeks after birth • Pediatric FACES, used for patients from ages 3 to 7 years (3)
• FLACC (Face, Legs, Activity, Cry, Consolability) Scale for nonverbal patients (4)(5) A numeric scale from 0 to 10 is commonly used for children who are older and can self-report a number. Clinicians must remember to ask the patient, unless he or she is unable to communicate, about the level of pain. Parents might over-or underreport their child's degree of pain. Also, asking the patient begins to nurture a therapeutic relationship that continues with pain treatment.
TYPES OF PAIN
The diagnostic groups of pain are defined by their mechanistic causes. Nociceptive pain is usually due to tissue damage (mechanical or traumatic) or inflammation and can be classified as somatic or visceral. Visceral pain affects the internal organs and the soft tissue of the body. It is commonly described as being sore, gnawing, achy, pressure, or cramping. Somatic type pain is described more often as constant, worsening with movement, sharp, throbbing, and is usually localized to a specific body area such as an extremity or the back. Neuropathic pain is usually due to nerve fiber damage (pressure, trauma, swelling, inflammation) or entrapment of nerves. Neuropathic pain is best described as burning, shooting, and stinging and can be associated with skin color changes (autonomic vasomotor changes) or an inability to tolerate even light touch without experiencing pain. Distinguishing between acute and chronic pain is also important. Acute pain is experienced when there is an injury to a body tissue. As healing occurs, the pain resolves. The goal of managing acute pain is to relieve the pain during the body's healing process. However, there is a propensity to develop hyperalgesia in areas of repetitive tissue damage (eg, repeated heel lancing in an infant) where the "field" of receptors becomes hypersensitive to less invasive sensation. Chronic pain persists after the initial insult has "healed." The causative agent cannot be removed. The overall treatment goal for a patient with chronic pain is functional improvement; total pain relief is rarely achievable. Chronic pain has been demonstrated to cause central nervous system changes affecting feelings and complex thoughts. (6)(7)(8)
PAIN MANAGEMENT
Management depends on the category or type of pain. Nociceptive pain is treated with nonsteroidal anti-inflammatory drugs for mild pain, with the addition of opioids for moderateto-severe nociceptive pain. An important point is that many orally administered opioid medications contain acetaminophen. Therefore, the patient and parents/caregivers should be specifically counseled about the potential cumulative effect of acetaminophen and reminded not to take other medications containing acetaminophen so as to minimize the potential for liver toxicity. Also, codeine is no longer recommended for children due to the potential for acute overdose in those who have hypermetabolism, a genetic predisposition that is generally unknown to the patient or clinician. (9) Affected children rapidly metabolize codeine into morphine and are more prone to respiratory depressant effects. Therefore, only hydrocodone or oxycodone should be used if an opioid is necessary.
Clinicians must recognize the different potencies of opioids, especially when they are changing a prescription between intravenous and enteral formulations. For example, intravenous morphine is three times more potent than oral morphine. Also, oxycodone is more potent than morphine and hydrocodone in enteral formulation. Therefore, clinicians should work with a pharmacist, palliative care clinician, or pain/anesthesia specialist when treating a patient with any opioid or use references that assist in determining equivalent intravenous and enteral dosing.
Neuropathic pain is treated with gabapentinoids. The theory behind using the gabapentinoids is their inhibition of excitation within the central nervous system. The two common medications used are gabapentin and pregabalin. Other medications that affect the central nervous system can also be used, including tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, and anticonvulsants. Chronic opioid therapy has no role in the treatment of neuropathic pain.
Other, nonpharmaceutical treatment modalities for pain management often prove more effective for patients experiencing pain or other symptoms related to an underlying condition or adverse effects from treatments. Such interventions include biofeedback, guided imagery, meditation, hypnosis, and acupuncture. Among the physical measures that can prove 
SYMPTOM MANAGEMENT
Symptom management in children requires astute attention to clinical assessment tools and scales. It is important for the child to contribute to this assessment by answering specific questions after being presented age-appropriate cues. (10) Admittedly, this approach may pose a challenge with a child who has a chronic complex medical condition, but the results can be worthwhile. Generally, an otherwise healthy pediatric patient has acute symptoms related to one or two organ systems. The child who has a chronic complex medical condition usually has more than two organ systems affected, which can lead to multiple symptoms that require concomitant management. The most common symptoms in children with chronic complex medical conditions are pain, nausea and vomiting, dyspnea, fatigue, anorexia and weight loss, depression, anxiety, and sleep disturbances. Table 3 lists common medications used to relieve pain and other systemic signs and symptoms. Nausea, with or without vomiting, is the most common symptom other than pain in children with chronic medical conditions. Several physiologic mechanisms contribute to nausea and vomiting. Nausea is mediated through the autonomic nervous system. Distension of an organ within the abdominal cavity triggers the gastric mechanoreceptors that stimulate the vagal afferent fibers. Also, stimulation of receptors in the medulla by toxins or increased intracranial pressure can induce nausea. The vestibular system can also cause nausea with or without vomiting, but this is less commonly seen in the pediatric patient. Although nausea may be perceived as a problem, it also can serve to indicate the nature or locus of certain conditions that require assessment, such as increased intracranial pressure, adverse drug effects or exposure to toxic agents, or bowel distention that deters eating so as to mitigate ongoing gastrointestinal distress. If nausea accompanies chemotherapy or other medications that are necessary in a patient's care, its treatment may be essential to improve the patient's quality of life. Treatment may also make living with certain vestibular dysfunctions more bearable and facilitate eating.
Vomiting is coordinated by the vomiting center. Several afferent pathways lead to the vomiting center, including the chemoreceptor trigger zone, the cerebral cortex and limbic system, the vestibular system of the inner ear, and peripheral stimuli. The neural receptors involved in both the peripheral and central nervous system are mediated by dopamine receptor type 2, serotonin receptor type 3, histamine receptor type 1, and muscarinic cholinergic receptors. Like nausea, vomiting may indicate an underlying problem requiring identification and correction or be an adverse effect of necessary medical management (eg, medications) for which treatment of the vomiting may be useful.
The choice of pharmaceutical agent for treatment of nausea and vomiting is based on the likely pathway affected in the vomiting center. For example, most chemotherapeutic agents affect the chemoreceptor trigger zone, which is the reason for frequently using promethazine before chemotherapy administration.
Metoclopramide can be used if gastric distension is suspected as the underlying cause of nausea. Scopolamine or glycopyrrolate may be appropriate if nausea is attributed to the vestibular system. If increased intracranial pressure is suspected, dexamethasone is indicated. Ondansetron, a serotonin 5-HT3 receptor antagonist, may be used in children older than 4 years to prevent postoperative nausea and vomiting, or that associated with chemotherapy.
Constipation is a common adverse effect of opioid pain medication, dehydration, decreased ambulation, or diet. A bowel regimen that mitigates constipation should be simultaneously prescribed for any patient receiving long-term opioids. Constipation often leads to nausea and, at times, vomiting. Laxatives and stool softeners are the mainstay of treatment for constipation. It is important to use the most effective combinations to maintain regular bowel movements while not causing more gastrointestinal distress.
Dyspnea is defined as feeling short of breath, which may be due to actual difficulty in breathing or to chest wall or pleural pain associated with breathing. Results of the traditional respiratory assessment, including respiratory rate, oxygen saturation, and blood gases, do not always correlate with the patient's report of breathlessness. Dyspnea scales used in some adult populations, such as those with chronic obstructive pulmonary disease, are not applicable to children. The best studied dyspnea scale in pediatrics is the Dalhousie Dyspnea Scale (Figure) which has been used in children with asthma or cystic fibrosis. (11) Causes of dyspnea include an underlying pulmonary disease, anemia, airway obstruction, and heart failure. A trial of supplemental oxygen, a fan blowing on the patient's face, repositioning, and relaxation techniques are suggested treatments. Anxiolytics, such as lorazepam, are used to control anxiety that may contribute to the sensation of shortness of breath, especially in end-of-life situations. Morphine sulfate is commonly used by palliative care practitioners to control dyspnea but in lower doses than used for pain management, such as 0.05 mg/kg administered intravenously or subcutaneously. Fatigue is often experienced by patients as they enter the last months of life, and this becomes an area of focus and concern for both the patient and caregivers. Anemia, infection, uncontrolled pain, deconditioning, poor dietary intake, sleep disturbances, depression, anxiety, and adverse effects of medications all may contribute to fatigue. The treatment should focus initially on treatment of underlying causes such as depression, anxiety, or sleep disturbances. The patient also should be encouraged to take frequent naps or modify activities. At times, methylphenidate can be used to increase the patient's wakefulness, especially for important events that the patient and family desire.
CONCLUSION
Although not exhaustive, this review is intended to assist the clinician in taking a thoughtful approach to pain and symptom assessment and management in children with complex and chronic medical conditions. Symptoms may wax and wane over the course of the child's life, at key times in development or with certain activities, or during hospitalizations for acute decompensations from a primary life-limiting disease. When causes of symptoms are understood, they can be anticipated and addressed, even before the child's end of life. In so addressing them, clinicians contribute to improved comfort and an enhanced quality of life for the patient and his or her family. Pediatric palliative care is a growing specialty, as evidenced by Accreditation Council for Graduate Medical Education-approved fellowship programs and the growth of inpatient and outpatient palliative care services associated with children's hospitals worldwide. Palliative care physicians are trained in recognizing and treating pain and symptoms in children with chronic medical conditions. By gaining knowledge about the common symptoms and initial treatments for such pain, treating clinicians can begin therapy while awaiting a referral to the appropriate subspecialist.
Based on consensus, the earlier a patient's pain and symptoms are addressed and managed, the sooner he or she can return to a previous level of function. The keys to the treatment plan can be found in the history and details related to the characteristics of the pain. Evaluation should encompass current medications or treatments that could be causing the pain, prompting clinicians occasionally to discontinue or change treatment. Appropriate early treatment can enhance the patient-clinician relationship and bring satisfaction to the treating clinician who is providing relief to the patient.
NOTE: The authors have made every effort to attempt to check specific medication dosing for accuracy. Due to incomplete pediatric dosing information on some drugs, we recommend the reader check current specific product information and published literature, or consult your pharmacist, for questions. CME quiz and references for this article are at http://pedsinreview. aappublications.org/content/36/12/527.full.
